AQR Capital Management’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.03M | Buy |
111,022
+95,372
| +609% | +$885K | ﹤0.01% | 2194 |
|
|
2025
Q1 | $115K | Sell |
15,650
-10,629
| -40% | -$77.9K | ﹤0.01% | 2992 |
|
|
2024
Q4 | $224K | Buy |
26,279
+8,791
| +50% | +$75.1K | ﹤0.01% | 2626 |
|
|
2024
Q3 | $152K | Buy |
+17,488
| New | +$152K | ﹤0.01% | 2615 |
|
|
2024
Q2 | – | Sell |
-11,755
| Closed | -$107K | – | 2655 |
|
|
2024
Q1 | $107K | Sell |
11,755
-40,473
| -77% | -$368K | ﹤0.01% | 2332 |
|
|
2023
Q4 | $233K | Sell |
52,228
-14,976
| -22% | -$66.8K | ﹤0.01% | 2159 |
|
|
2023
Q3 | $211K | Buy |
67,204
+24,974
| +59% | +$78.4K | ﹤0.01% | 2126 |
|
|
2023
Q2 | $218K | Sell |
42,230
-288
| -0.7% | -$1.49K | ﹤0.01% | 2062 |
|
|
2023
Q1 | $224K | Sell |
42,518
-70,092
| -62% | -$369K | ﹤0.01% | 2020 |
|
|
2022
Q4 | $316K | Buy |
112,610
+99,628
| +767% | +$280K | ﹤0.01% | 1956 |
|
|
2022
Q3 | $54K | Sell |
12,982
-22,360
| -63% | -$93K | ﹤0.01% | 2146 |
|
|
2022
Q2 | $142K | Buy |
35,342
+6,947
| +24% | +$27.9K | ﹤0.01% | 2044 |
|
|
2022
Q1 | $141K | Buy |
28,395
+6,675
| +31% | +$33.1K | ﹤0.01% | 2109 |
|
|
2021
Q4 | $151K | Sell |
21,720
-42,962
| -66% | -$299K | ﹤0.01% | 2122 |
|
|
2021
Q3 | $647K | Buy |
64,682
+6,007
| +10% | +$60.1K | ﹤0.01% | 1761 |
|
|
2021
Q2 | $832K | Sell |
58,675
-6,402
| -10% | -$90.8K | ﹤0.01% | 1661 |
|
|
2021
Q1 | $1.07M | Buy |
65,077
+16,291
| +33% | +$267K | ﹤0.01% | 1521 |
|
|
2020
Q4 | $1.01M | Sell |
48,786
-7,829
| -14% | -$162K | ﹤0.01% | 1504 |
|
|
2020
Q3 | $431K | Sell |
56,615
-16,595
| -23% | -$126K | ﹤0.01% | 1788 |
|
|
2020
Q2 | $610K | Buy |
+73,210
| New | +$610K | ﹤0.01% | 1668 |
|
|
2017
Q4 | – | Sell |
-21,256
| Closed | -$131K | – | 2261 |
|
|
2017
Q3 | $131K | Buy |
+21,256
| New | +$131K | ﹤0.01% | 2215 |
|